Evidence map›Paper›PMID 34890253›Full record

ArticleScience immunology2021

Effective CD4 T cell priming requires repertoire scanning by CD301b

Naoya Tatsumi, Alicia L Codrington, Jihad El-Fenej, Varoon Phondge, Yosuke Kumamoto

Open access · greenAbstract read
In one paragraph

Article in Science immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. CD301bNature communications · 2025
    Article
  11. Review
  12. The role of IL-2 in type 2 immunity.Frontiers in immunology · 2025
    Review
  13. Macro-clusters: CD301b+ DCs prime Th2 responses.The Journal of experimental medicine · 2024
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Naoya TatsumiCenter for Immunity and Inflammation, Rutgers New Jersey Medical School, Newark, NJ 07103, USA.ORCID 0000-0002-8277-0660
Alicia L CodringtonCenter for Immunity and Inflammation, Rutgers New Jersey Medical School, Newark, NJ 07103, USA.
Jihad El-FenejCenter for Immunity and Inflammation, Rutgers New Jersey Medical School, Newark, NJ 07103, USA.
Varoon PhondgeCenter for Immunity and Inflammation, Rutgers New Jersey Medical School, Newark, NJ 07103, USA.ORCID 0000-0002-5799-0549
Yosuke KumamotoCenter for Immunity and Inflammation, Rutgers New Jersey Medical School, Newark, NJ 07103, USA.ORCID 0000-0001-9369-4934
Rutgers, The State University of New Jersey · US

Funding

Regulation of Th2 differentiation by skin-resident dendritic cellsR01AI132576 · NIAID · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI YOSUKE KUMAMOTO · 2017 to 2026
$3.8M
NIAID NIH HHS R01 AI132576
6 · The paper itself

Abstract

During the initiation of adaptive immune responses, millions of lymphocytes must be scanned to find the few cognate clones. The activation mechanisms of CD4 T cells have been extensively studied, but the cellular mechanisms that drive selection of cognate clones are not completely understood. Here, we show that recently homed naïve polyclonal CD4 T cells are temporarily retained before leaving the lymph node. This stop-and-go traffic of CD4 T cells provides an adequate time window for efficient scanning and timely priming of antigen-specific cognate clones. CD301b

Indexed as

AnimalsCD4-Positive T-LymphocytesDendritic CellsLectins, C-TypeLymph NodesMiceMice, CongenicMice, Inbred C57BLMice, KnockoutMice, TransgenicLectins, C-TypeMGL2 protein, mouse

Identifiers

PMID34890253
PMCPMC8832498
OpenAlexW4200430173

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.